SEC Form 4 · accession 0001731122-18-000141
Enochian Biosciences Inc · ENOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rene Sindlev
Director · 10% Owner
Period of report
Feb 16, 2018
Accepted (ET)
Nov 7, 2018 · 9:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001527728
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 16, 2018 | X | 1,000,000 | $1.30 | A | 4,770,869 | I | By RS Group ApS |
| Common Stock | Feb 16, 2018 | X | 250,000 | $2.00 | A | 5,020,869 | I | By RS Group ApS |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to Purchase Common Stock | $1.30 | Feb 16, 2018 | X | 1,000,000 | D | May 15, 2017 | Apr 21, 2022 | Common Stock | 1,000,000 | 4,400,000 | I |
| Warrant to Purchase Common Stock | $2.00 | Feb 16, 2018 | X | 250,000 | D | Oct 17, 2017 | Dec 31, 2019 | Common Stock | 250,000 | 0 | I |